Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-06

Clinical Trial Update: Preventing Tobacco Relapse With Omega-3s Trial [NA]

View source ↗

Summary

A Vanderbilt-led trial investigating omega-3 fatty acids to prevent tobacco relapse has been withdrawn from clinical investigation. The sponsor lists Tobacco De…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Tobacco Dependence | NA | Status: WITHDRAWN